Suggestions
Andrew ElBardissi, MD
Partner at Deerfield Management
Andrew ElBardissi, MD, is a prominent figure in the healthcare investment sector, currently serving as a Board Member at Medical Microinstruments, Inc. since June 2022. He is also a Partner at Deerfield Management, where he has been instrumental in focusing on structured transactions within the firm's Private Design Funds since 2017. His extensive board experience includes positions at various innovative healthcare companies such as Aurion Biotech, Bitteroot, and Epic Sciences, among others.123
Educational Background
- Doctor of Medicine (M.D.) from Mayo Medical School.
- Master of Public Health (M.P.H.) in Quantitative Methods from Harvard University.
- Master of Business Administration (MBA) from Harvard Business School.
- Bachelor of Science (B.S.) with honors in Biology from the Schreyer Honors College at Pennsylvania State University.12
Professional Experience
ElBardissi's career has spanned various roles:
- Healthcare Investment Banking Associate at J.P. Morgan, where he led significant transactions in biotech and medical technology.
- Cardiothoracic Surgery Resident at Stanford University School of Medicine and General Surgery Resident at Brigham and Women's Hospital affiliated with Harvard Medical School.123
He has a strong research background, having received independent funding for projects aimed at improving patient safety in cardiac surgery and has published over 30 articles in peer-reviewed journals.23
Contributions to Medical Microinstruments
At Medical Microinstruments, ElBardissi plays a crucial role in advancing robotic microsurgery technologies. He has expressed enthusiasm about the potential of the company's Symani Surgical System to transform microsurgical procedures, emphasizing its capability to enhance surgical precision and improve patient outcomes.3
Highlights

